Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Genus Lifesciences Inc.
EIR
•Genus Lifesciences Inc.•September 29, 2017

Genus Lifesciences Inc. – FDA EIR, Sep 29, 2017

Record Details

Genus Lifesciences Inc., a manufacturer of controlled and non-controlled drug products in Allentown, PA, underwent a full cGMP surveillance inspection by the FDA from September 25-29, 2017. The inspection, conducted under Title 21 of the Code of Federal Regulations (21 CFR) Part 210 & 211, identified significant deficiencies in their quality control and operational systems. At the inspection's conclusion, the company received a two-item FDA-483. The primary violations included incomplete laboratory records, specifically the omission of data from test injections, lack of documented audit trail reviews for electronic data, and inadequate validation of Excel spreadsheets used for calculations. A critical concern was the absence of appropriate controls over computer systems, demonstrated by an analyst's ability to delete raw data files from an FT-IR instrument. Verbally discussed issues included inconsistent adherence to change control procedures, failure to establish "dirty hold time" during cleaning validation, and unresolved consumer complaints regarding cloudy Potassium Chloride oral solution due to precipitation. The company acknowledged these observations and was directed to submit a written response detailing corrective actions to the FDA within fifteen business days.

Company
Genus Lifesciences Inc.
Inspection date
September 29, 2017
Product type
drugs
Office
Philadelphia District Office
Person
  • Toyin B. Oladimeji (issuing_officer)
View Company Profile

ID · 4601c938-2073-46cd-8af7-5238c32e2425

Violation Codes3
21 CFR 21021 CFR 21121 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Genus Lifesciences Inc.
  • EIR - 2024-07-31July 31, 2024
  • 483 - 2019-09-20September 20, 2019
  • EIR - 2018-11-28November 28, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Genus Lifesciences Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.